Literature DB >> 7453005

Therapy of urea cycle enzymopathies: three case studies.

M L Batshaw, M J Painter, G T Sproul, I A Schafer, G H Thomas, S Brusilow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7453005

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN： 0021-7263


× No keyword cloud information.
  5 in total

Review 1.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

2.  Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.

Authors:  M L Batshaw; S W Brusilow
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.

Authors:  B A Barshop; J Breuer; J Holm; J Leslie; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Identification and application of additional restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.

Authors:  J E Fox; A M Hack; W A Fenton; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

Review 5.  Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.

Authors:  A Cartagena; A N Prasad; C A Rupar; M Strong; M Tuchman; N Ah Mew; C Prasad
Journal:  Can J Neurol Sci       Date:  2013-01       Impact factor: 2.104
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.